Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suit-Fong Chan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Molecular Diagnostics : JMD|April 8, 2023
Preanalytic Methodological Considerations and Sample Quality Control of Circulating miRNAsSuit-Fong Chan, He Cheng, Karen Kai-Rui Goh, et al.
Scientific Reports|July 14, 2026
A practical and accessible workflow for bulk TCR sequencing from buffy coat samples without T cell enrichmentJolene Caifeng Ho, Ah-Jung Jeon, Ming Xue Wee, et al.
Cancer Letters|January 24, 2012
Anti-angiogenic therapy renders large tumors vulnerable to immunotherapy via reducing immunosuppression in the tumor microenvironmentSuit-Fong Chan, Hao-Tien Wang, Kai-Wen Huang, et al.
Hepatology (Baltimore, Md.)|February 28, 2007
Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumorsChun-Jung Chang, Yi-Hsiang Chen, Kai-Wen Huang, et al.
Cancer Treatment and Research Communications|May 28, 2026
Development and validation of a plasma miRNA-CEA biomarker panel for early detection of lung cancerJoji Samejima, Li Zhou, Toru Kimura, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Molecular Diagnostics : JMD|April 8, 2023
Preanalytic Methodological Considerations and Sample Quality Control of Circulating miRNAsSuit-Fong Chan, He Cheng, Karen Kai-Rui Goh, et al.
Scientific Reports|July 14, 2026
A practical and accessible workflow for bulk TCR sequencing from buffy coat samples without T cell enrichmentJolene Caifeng Ho, Ah-Jung Jeon, Ming Xue Wee, et al.
Cancer Letters|January 24, 2012
Anti-angiogenic therapy renders large tumors vulnerable to immunotherapy via reducing immunosuppression in the tumor microenvironmentSuit-Fong Chan, Hao-Tien Wang, Kai-Wen Huang, et al.
Hepatology (Baltimore, Md.)|February 28, 2007
Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumorsChun-Jung Chang, Yi-Hsiang Chen, Kai-Wen Huang, et al.
Cancer Treatment and Research Communications|May 28, 2026
Development and validation of a plasma miRNA-CEA biomarker panel for early detection of lung cancerJoji Samejima, Li Zhou, Toru Kimura, et al.
Pageof 1